Your session is about to expire
← Back to Search
Rehabilitation for Spinal Muscular Atrophy
Study Summary
This trial studies an outpatient rehab program for SMA-affected children ages 6 months - 3 years, providing 45 minutes of OT & PT per week plus home exercises for 12 weeks, followed by 12 weeks without therapy. Assessments & program evaluations at start & end.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child can understand and follow instructions in English.I am receiving treatment that targets my cancer's genetic changes.I am between 6 months and 3 years old.I can attend weekly therapy sessions in person at Holland Bloorview.I use a tracheostomy or need ventilation during the day.I can bring my breathing device to weekly therapy sessions if needed.I have been diagnosed with Spinal Muscular Atrophy (SMA) Type I, II, or III.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research accept elderly participants?
"This clinical trial's eligibility criteria requires participants to be aged between 6 Months and 3 Years. There are 49 studies for minors and 154 examinations that elderly patients can volunteer in."
What is the highest number of participants this research endeavor can accommodate?
"Affirmative. Clinicaltrials.gov confirms that this research endeavor, which was first unveiled on the 1st of January 2022, is still ongoing and looking for applicants. Aspiring participants will be drawn from a single location with only 10 spots available in total."
Are any additional participants being solicited to join this experiment?
"Affirmative, the data from clinicaltrials.gov indicates that this trial is actively recruiting patients. Initially posted on January 1st 2022 and last updated on August 2nd 2023, 10 volunteers need to be recruited at one site."
Who would be a suitable candidate for participating in this experiment?
"This investigation seeks 10 infants or toddlers between 6 months and 3 years of age with Spinal muscular atrophy. Prospective participants must fulfil the following requirements: SMA (Type I, II or III) diagnosis; genetic based therapy; attend weekly in-person sessions at Holland Bloorview; bring suitable respiratory devices to each session if required; substitute decision makers that are able to converse and read English fluently; child's capacity to comprehend/follow directions in English as appropriate for their age group; SDMs' permission on behalf of the participating minor."
Share this study with friends
Copy Link
Messenger